A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19

NCT04558021 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

DRUG: Niclosamide suspension
OTHER: Placebo

Sponsor

Imuneks Farma ilac San. Tic. A.S.